| Patents for C07K - Peptides (3,738) |
|---|
| 12/08/2010 | CN1803837B Neurotrophic growth factor |
| 12/02/2010 | US20100303836 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 11/30/2010 | CA2430772C Humanized antibodies that recognize beta amyloid peptide |
| 11/25/2010 | US20100297629 Nucleic acid supported protein complementation |
| 11/25/2010 | US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides |
| 11/25/2010 | US20100294716 Templated Native Silk Smectic Gels |
| 11/24/2010 | EP2253703A1 Human coagulation factor VII variants |
| 11/17/2010 | EP1648919B1 Methods for detecting activation of t-cells by mhc binding peptides |
| 11/16/2010 | US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 11/16/2010 | CA2422622C Novel baff-r nucleic acids and polypeptides |
| 11/16/2010 | CA2261334C Bovine polynucleotide vaccine for the intradermal route |
| 11/09/2010 | CA2161684C Bioactive and/or targeted dendrimer conjugates |
| 11/04/2010 | US20100278857 Dendritic Cell Binding Proteins and Uses Thereof |
| 11/03/2010 | EP2246362A2 Polymer conjugates of mutated neublastin |
| 11/03/2010 | EP1261718B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/02/2010 | US7825131 Quinoline potassium channel inhibitors |
| 11/02/2010 | CA2330170C Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 10/28/2010 | US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds |
| 10/28/2010 | US20100273233 Amyloid specific peptides and uses thereof |
| 10/26/2010 | US7820671 Peptidomimetic protease inhibitors |
| 10/20/2010 | EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis |
| 10/20/2010 | EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 10/14/2010 | US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 10/14/2010 | US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 10/12/2010 | US7812158 Coupling agents for peptide synthesis |
| 10/12/2010 | US7812116 Immunogenic peptides |
| 10/12/2010 | US7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes |
| 10/12/2010 | US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell |
| 10/12/2010 | CA2419205C Anti-tnf antibodies, compositions, methods and uses |
| 10/07/2010 | US20100256698 Isoquinolinone Potassium Channel Inhibitors |
| 10/06/2010 | EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds |
| 10/05/2010 | US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders |
| 09/30/2010 | US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/30/2010 | US20100247648 Antimicrobial compounds |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/28/2010 | US7803924 Polynucleotide encoding a protein that is highly immunogenic especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens |
| 09/28/2010 | US7803562 Method for screening human intestinal Npt2B modulatory agents |
| 09/22/2010 | EP2230299A1 Novel cytokine ZCYTOR17 ligand |
| 09/21/2010 | US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 09/21/2010 | CA2307142C N-terminally chemically modified protein compositions and methods |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/15/2010 | EP1309617B1 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 09/14/2010 | US7794947 Affinity capture of peptides by microarray and related methods |
| 09/08/2010 | EP2226385A1 Human Coagulation Factor VII Variants |
| 09/08/2010 | EP1611151B1 Stq-peptides |
| 09/07/2010 | US7790855 Used to diagnose and treat various diseases, including human cancers associated with expression and/or over-expression of KID3 |
| 09/02/2010 | US20100222233 Affinity capture of peptides by microarray and related methods |
| 09/02/2010 | US20100221254 Methods and Compositions for PDGF-C Activation and Inhibition |
| 08/31/2010 | US7786286 Microorganismal, outer-membrane, enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 08/26/2010 | US20100216824 Anti-cancer cyclopenta [G]quinazonline compounds |
| 08/25/2010 | EP1594436B1 Mutated neublastin |
| 08/19/2010 | US20100209493 HLA-A2 Tumor Associated Antigen Peptides and Compositions |
| 08/18/2010 | CN1729018B G-CSF conjugates |
| 08/17/2010 | US7777001 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies |
| 08/17/2010 | US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 07/29/2010 | US20100190660 Methods, Compositions And Libraries Pertaining To PNA Dimer And PNA Oligomer Synthesis |
| 07/27/2010 | US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors |
| 07/27/2010 | US7763253 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 07/20/2010 | US7759116 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/13/2010 | US7754678 fusion proteins; drug delivery |
| 07/06/2010 | US7751987 Method and system for predicting amino acid sequences compatible with a specified three dimensional structure |
| 07/06/2010 | US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof |
| 07/06/2010 | US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 07/06/2010 | CA2539814C Isoquinolinone potassium channel inhibitors |
| 07/01/2010 | US20100168383 Skin or Hair Binding Peptides |
| 06/29/2010 | US7745569 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques |
| 06/29/2010 | US7745405 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence; fusion proteins for tissue-targeted therapy |
| 06/29/2010 | US7745397 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 06/24/2010 | US20100160174 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 06/23/2010 | CN101745112A Treatment of TNFalpha related disorders |
| 06/22/2010 | US7740834 Murine zcytor17 ligand polypeptides |
| 06/22/2010 | CA2216963C Tie-2 ligands, methods of making and uses thereof |
| 06/08/2010 | US7731971 for use in second generation HIV vaccines and as diagnostic tools in the treatment and control of HIV infection; define a critical balance between MHC affinity and receptor crossreactivity required for effective epitope enhancement and also demonstrate construction and efficacy of |
| 06/03/2010 | US20100137583 Peptidomimetic protease inhibitors |
| 06/03/2010 | US20100137219 Methods and Compositions for Inhibiting Binding IgE to a High Affinity Receptor |
| 06/03/2010 | US20100136054 Flavivirus ns1 subunit vaccine |
| 06/03/2010 | US20100136011 Antibodies that bind to obm |
| 06/03/2010 | US20100135910 Modulation of Anergy and Methods for Isolating Anergy-Modulating Compounds |
| 06/02/2010 | EP2192192A1 Kinase and phosphatase assays |
| 06/02/2010 | EP1534736B1 Nogo receptor antagonists |
| 05/26/2010 | CN1751064B Hsp60 from arthrobacter |
| 05/26/2010 | CN1468308B Anti-TNF antibodies, compositions, methods and uses |
| 05/25/2010 | US7723470 Antibiotic of given structure; vancomycin derivatives; enhanced activity, selectivity and reduced mammalian toxicity |
| 05/25/2010 | US7723469 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability |
| 05/25/2010 | US7723352 Isoquinolinone potassium channel inhibitors |
| 05/18/2010 | US7718779 Prophylactic and therapeutic monoclonal antibodies |
| 05/13/2010 | US20100121038 Template-directed assembly of receptor signaling complexes |
| 05/13/2010 | US20100121027 Cyclic Peptide Compositions for Treatment of Sexual Dysfunction |
| 05/12/2010 | CN1916025B Analogs of parathyroid hormone |
| 05/12/2010 | CN1426423B Humanized antibodies that sequester amyloid beta peptide |
| 05/11/2010 | US7713934 Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val, or a C-terminal truncated fragment of the polypeptide having six or more amino acids. Xaa is alanine, glycine, serine, or an S-protected cysteine; wound healing agent, cardiac repair, bone, promote cartilage repair or growth; antirestenosis |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 04/28/2010 | EP1664332B1 Kinase and phosphatase assays |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7704685 In vivo production of a clostridial neurotoxin light chain peptide |
| 04/27/2010 | CA2222129C A method for producing influenza hemagglutinin multivalent vaccines |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |